MedTrace Logo

The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation

NCT07066605 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-07-15

No results posted yet for this study

Summary

This study aims to evaluate the effect of dexmedetomidine on the level of agitation during the weaning process from mechanical ventilation in critically ill patients.

Conditions

  • Dexmedetomidine

Interventions

DRUG

Group A (Dexmedetomidine Group)

patients will receive dexmedetomidine infusion starting at 0.2 mcg/kg/hr.

DRUG

Group B (Control Group)

patients will receive standard ICU sedation protocol without dexmedetomidine (e.g., fentanyl)

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-13
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07066605 on ClinicalTrials.gov